RE 19 (Atenolol 25 mg)
Pill imprint RE 19 has been identified as Atenolol 25 mg.
Atenolol is used in the treatment of anxiety; high blood pressure; alcohol withdrawal; migraine prevention; angina (and more), and belongs to the drug class cardioselective beta blockers. There is positive evidence of human fetal risk during pregnancy. Atenolol 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- RE 19
- Strength:
- 25 mg
- Color:
- White
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Cardioselective beta blockers
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Ranbaxy Pharmaceuticals Inc.
- National Drug Code (NDC):
- 63304-0621
- Inactive Ingredients:
- magnesium carbonate
magnesium stearate
silicon dioxide colloidal
sodium lauryl sulfate
sodium starch glycolate type A potato
corn starch
| NDC Code | Manufacturer / Repackager |
|---|---|
| 21695-0322 | Rebel Distributors Corp (repackager) |
| 53002-1108 | Pharmedix (repackager) |
Note: Inactive ingredients may vary.
More about atenolol
Consumer resources
- Other brands: Tenormin
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
